Bellisai Giulia, Bernasconi Giovanni, Brancato Alba, Carrasco Cabrera Luis, Ferreira Lucien, Giner German, Greco Luna, Jarrah Samira, Kazocina Aija, Leuschner Renata, Magrans Jose Oriol, Miron Ileana, Nave Stefanie, Pedersen Ragnor, Reich Hermine, Ruocco Silvia, Santos Miguel, Scarlato Alessia Pia, Theobald Anne, Vagenende Benedicte, Verani Alessia
EFSA J. 2021 Aug 30;19(8):e06824. doi: 10.2903/j.efsa.2021.6824. eCollection 2021 Aug.
In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Syngenta France S.A.S. submitted a request to the competent national authority in France to modify the existing maximum residue levels (MRLs) for emamectin. The data submitted in support of the request were found to be sufficient to derive MRL proposals for apricots, cherries, spinaches and similar leaves and herbal infusions from leaves and herbs, whereas a change of the existing MRL is not necessary for pome fruits. Adequate analytical methods for enforcement are available to control the residues of emamectin B1a on the commodities under consideration. Based on the risk assessment results, EFSA concluded that the short-term and long-term intake of residues resulting from the uses of emamectin benzoate according to the intended agricultural practices are unlikely to present a risk to consumer health. The consumer risk assessment shall be regarded as indicative since affected by uncertainty related to the data gaps identified in the MRL review.
根据欧盟法规（EC）No 396/2005第6条，申请人先正达法国股份公司向法国国家主管当局提交了一份申请，请求修改甲氨基阿维菌素苯甲酸盐的现有最大残留限量（MRLs）。经审查，提交的支持该申请的数据足以得出杏子、樱桃、菠菜及类似叶片以及叶类和草本植物的草药浸剂中甲氨基阿维菌素的最大残留限量建议，而对于梨果而言，无需更改现有最大残留限量。现有足够的执法分析方法来控制所涉商品中甲氨基阿维菌素B1a的残留量。基于风险评估结果，欧洲食品安全局得出结论，按照预期农业操作使用甲氨基阿维菌素苯甲酸盐产生的残留量短期和长期摄入对消费者健康不太可能构成风险。由于最大残留限量审查中发现的数据缺口存在不确定性，消费者风险评估应被视为指示性的。
